Generic Name and Formulations:
Betamethasone (as dipropionate) 0.05%, clotrimazole 1%; crm; lotion.
Merck & Co., Inc.
Indications for LOTRISONE:
Fungal skin infections.
Apply sparingly twice daily; max 45g (cream), 45mL (lotion) per week. Max 2 wks for t. cruris, t. corporis; 4 wks for t. pedis.
Do not occlude. Use lowest effective dose (esp. in children). Monitor patients regularly. Discontinue steroid if infection persists, worsens or superinfection occurs. Pregnancy (Cat.C). Nursing mothers.
Steroid + azole antifungal.
Irritation, erythema, stinging, folliculitis, hypertrichosis, dermatitis, HPA axis suppression (esp. in children), epidermal and dermal atrophy (esp. in thin-skinned or occluded areas).
Crm—15g, 45g; Lotion—30mL
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA Fast-Tracks Treatment for Autism Spectrum Disorder
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics